Exploring the Dynamics of Immune Checkpoint Inhibitor-Induced Eosinophilia in Advanced/Metastatic Melanoma: A Comprehensive Retrospective Analysis.

Cancer Med · 2025 · PMC11947752 · PMID 40145321

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Although not statistically significant, there was a numerical trend suggesting higher overall survival (OSI) in patients with eosinophilia (42.6 months [95% CI, 26.3–58.8]) compared to those without eosinophilia (27.9 months [95% CI, 19.8–36.1]), with a two‐sided p ‐value of 0.178.

also in 488 other papers

an observed trendno p-value reported

Our study did not identify a significant association between its occurrence and overall survival, despite an observed trend toward a higher median OS I in patients with eosinophilia.

also in 242 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.